@prefix orcid: . @prefix this: . @prefix sub: . @prefix np: . @prefix dct: . @prefix pav: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix biolink: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { a biolink:ChemicalEntity; rdfs:label "iloperidone" . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "schizophrenia" . a biolink:OrganismTaxon; rdfs:label "adults" . sub:_1 rdf:object ; rdf:predicate biolink:treats; rdf:subject ; a rdf:Statement; biolink:has_population_context . } sub:provenance { sub:assertion prov:generatedAtTime "2022-07-01T09:20:20+00:00"^^xsd:dateTime; prov:hadPrimarySource ; prov:wasAttributedTo orcid:0000-0002-1501-1082; prov:wasQuotedFrom "Iloperidone tablets are indicated for the treatment of schizophrenia in adults." . biolink: pav:version "v.2.4.4" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB"; npx:hasSignature "ZUyXzsJowl9eACQou6sDtrZ8Ez/aUi1gcwk6zzC59QJR8yH/BeAciJCA8JB77A1lVfMZBKjGz7syh5Y7MDL5UnNAA6CnYMo4o3PyuDN9EMu3/3GN3Z8ku/cdA/kkTwo5vAzR9k39WE6RztjMvmemNMfzBe7kMOrjbpkeDf0fizE="; npx:hasSignatureTarget this: . this: dct:created "2022-07-01T09:20:20+00:00"^^xsd:dateTime; pav:createdBy orcid:0000-0002-1501-1082 . }